Assessing XEN microstent’s one-year efficacy: independent of site variability
XEN implantation yields consistent reductions in IOP and medication use across different centers using comparable surgical and postoperative treatment regime. These findings underscore XEN's short-term effectiveness and suggest standardizable outcomes regardless of exact surgical procedure or treatment differences.
Authors
- Jan Darius Unterlauft (ORCID: https://orcid.org/0000-0003-1469-0412)
- Caroline Bormann (ORCID: https://orcid.org/0000-0003-2176-706X)
- Matúš Rehák (ORCID: https://orcid.org/0000-0002-3257-6181)
- Focke Ziemssen (ORCID: https://orcid.org/0000-0002-3873-0581)
- Christian Scharenberg (ORCID: https://orcid.org/0000-0003-0235-4366)
Institutions
- Leipzig University of Applied Sciences (DE)
- Universität Innsbruck (AT)
- University Hospital of Bern (CH)
- Deutsches Herzzentrum der Charité (DE)
- University Hospital Leipzig (DE)
- University Hospital Innsbruck (AT)
- Leipzig University (DE)
Publication Details
- Journal
- International Journal of Ophthalmology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.18240/ijo.2025.01.10
- Primary Topic
- Fluid Dynamics and Turbulent Flows
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Biogen
- Alimera Sciences
- Bayer HealthCare
- Deutsche Forschungsgemeinschaft
- Novo Nordisk
- Universität Leipzig
- Allergan